Overview

A Study to Investigate the Safety and Tolerability of Single and Multiple Ascending Doses of KIT2014 in Healthy Subjects

Status:
COMPLETED
Trial end date:
2025-07-14
Target enrollment:
Participant gender:
Summary
This is the first-in-human study with KIT2014 designed to provide safety, tolerability and pharmacokinetic data in healthy volunteers.
Phase:
PHASE1
Details
Lead Sponsor:
Kither Biotech Srl
Collaborator:
Avance Clinical Pty Ltd.